Post by Formycon AG

9,797 followers

๐…๐จ๐ซ๐ฆ๐ฒ๐œ๐จ๐ง ๐ข๐ง๐ฏ๐ข๐ญ๐ž๐ฌ ๐ญ๐จ ๐œ๐จ๐ง๐Ÿ๐ž๐ซ๐ž๐ง๐œ๐ž ๐œ๐š๐ฅ๐ฅ ๐จ๐ง ๐ญ๐ก๐ž ๐ซ๐ž๐ฌ๐ฎ๐ฅ๐ญ๐ฌ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐Ÿ๐ข๐ซ๐ฌ๐ญ ๐ช๐ฎ๐š๐ซ๐ญ๐ž๐ซ ๐จ๐Ÿ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ” Formycon plans to publish its results for the first quarter of 2026 on May 28, 2026. The Management Board will discuss the companyโ€™s development, key financial figures, and provide an outlook for the course of 2026. The conference call, which will be broadcast live on the internet, will take place on Thursday, May 28, 2026, at 3:00 PM (CEST) in English To join the conference call on May 28, please use the following link: https://lnkd.in/dC4es_nr Further details and an overview of upcoming investor conferences in which Formycon will participate can be found in our Corporate News: https://lnkd.in/d4TrzwQQ #TeamFormycon #Biosimilars #FYB4Growth #Q1

Post content